The name spacelift was chosen by Prof. Mang and protected by patent (German Patent Office, Patent and Logogram No: 303 23891), as three-dimensional fat droplets of 0.1-0.3 mm are injected via the purified autologous fat cells into the space between the cutaneous and adipose tissue of the face, virtually as if in a honeycomb. As these fat droplets are not injected in a bolus dose but by using microinjections, they do not die but retain a vascular association and are transformed into fibroblasts, or rather connective tissue cells, and thus stabilize the aging process. Fat cells are thus injected into the space between the cutaneous and adipose tissue, particularly at those sites where the collagen and elastin fibers break down with age, i.e., in the nasolabial, mouth, forehead, lateral eye, and cheek regions.
The spacelift should be seen as a prophylaxis against aging after the 35th year of life. If there is surplus skin in the area of the neck/cheeks or eyelids, conventional tightening or lifting must be performed. A spacelift cannot replace a facelift.
The procedure is carried out on an outpatient basis under local anesthesia. Cooling and lymph drainage are then necessary for 3 days, along with antibiotic cover.
Was this article helpful?